Age

18–75

Sex

MALE

Healthy volunteers

Not accepted

Age less than 75 years
EORTC QLQC-30 score 2
Life expectancy of 10 years
Patients with oligometastatic prostate cancer on clinicopathological assessment
Patients are suitable for radiotherapy and prostatectomy surgery
Patients agree to participate in the study and sign the informed consent form before enrollment

Maximal Tumor Eradication for Oligometastatic Prostate Cancer